FindTrial
Sign In

Efficacy and safety of Paul glaucoma implants in the treatment of glaucoma

Retrospective study of Paul's glaucoma implant implantation for the treatment of refractory glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073856
Enrollment
Unknown
Registered
2023-07-24
Start date
2023-07-24
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

Operation group (Paul glaucoma implant treatment):NA

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Glaucoma was diagnosed; 2) Paul glaucoma implants were implanted; 3) Complete case data

Exclusion criteria

Exclusion criteria: 1) Paul glaucoma implant implantation was not performed; 2) The required case data is incomplete

Design outcomes

Primary

MeasureTime frame
IOP(intraocular pressure);visual acuity;—

Countries

China

Contacts

Public ContactZhang Hong

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

tjyksys@163.com+86 139 7167 9079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026